This report examines the potential impact and challenges of cancer vaccines, proposing a debate about the best and most equitable way to put an end to cancer. It includes illustrations by Daniel Hertzberg, and discusses the need for studies with clearly defined plans to treat a defined number of patients, as well as the potential of mobile production facilities for mRNA.
